指南与共识多重用药老年慢病共病管理

养老院居民膀胱炎经验性治疗的IOU共识推荐

The IOU Consensus Recommendations for Empirical Therapy of Cystitis in Nursing Home Residents.
指南 / 共识 · J Am Geriatr Soc · 2018-12-24

该共识采用两轮改良德尔菲法,由19名临床药师组成的专家小组对31条关于非导管留置养老院老年居民无并发症膀胱炎经验性抗感染治疗的推荐进行评分。第一轮应答率95%,3条推荐达成共识;第二轮应答率90%,另有8条推荐达成共识。共识推荐涵盖初始药物选择、不同肾功能水平下的剂量调整、需避免的药物相互作用及疗程。

要点

  • 共识推荐呋喃妥因或甲氧苄啶/磺胺甲噁唑作为初始治疗药物。
  • 需根据慢性肾脏病水平调整环丙沙星、呋喃妥因和甲氧苄啶/磺胺甲噁唑剂量。
  • 应避免甲氧苄啶/磺胺甲噁唑与华法林、苯妥英以及环丙沙星与茶碱或替扎尼定的相互作用。

核心结论

  • 临床药师专家小组能够就养老院老年居民膀胱炎经验性口服抗感染治疗达成一组共识推荐。
  • 该推荐已纳入非导管留置养老院居民无并发症膀胱炎的治疗算法,并用于正在进行的对照干预研究中的健康教育材料。

研究设计与样本

  • 两轮改良德尔菲调查,由19名临床药师组成的专家小组参与。
  • 研究组(包括一名老年临床药师、两名老年医学医师和一名感染病医师)进行综合文献检索并制定/审阅/编辑调查草案。
  • 专家组成员按5点Likert量表(1=强烈不同意至5=强烈同意)对31条推荐进行评分,共识定义为推荐-specific平均分的95%置信区间下限≥4.0。

主要发现

  • 第一轮应答率为95%,3条推荐达成共识(无慢性肾脏病者呋喃妥因和甲氧苄啶/磺胺甲噁唑的剂量,以及甲氧苄啶/磺胺甲噁唑与华法林的药物相互作用)。
  • 第二轮应答率为90%,另有8条推荐达成共识(2条关于呋喃妥因或甲氧苄啶/磺胺甲噁唑作为初始药物选择,3条关于不同慢性肾脏病水平下环丙沙星、呋喃妥因和甲氧苄啶/磺胺甲噁唑的剂量,3条关于需避免的药物相互作用:甲氧苄啶/磺胺甲噁唑与苯妥英,以及环丙沙星与茶碱或替扎尼定)。

关键数值与推荐

  • 共识达成标准:推荐-specific平均分的95%置信区间下限≥4.0(5点Likert量表)。

临床怎么用

  • 对非导管留置养老院老年居民无并发症膀胱炎,可参考本共识选择呋喃妥因或甲氧苄啶/磺胺甲噁唑作为初始经验性治疗药物。
  • 处方环丙沙星、呋喃妥因或甲氧苄啶/磺胺甲噁唑时,应根据患者慢性肾脏病水平调整剂量。
  • 应避免甲氧苄啶/磺胺甲噁唑与华法林、苯妥英合用,以及环丙沙星与茶碱或替扎尼定合用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To establish consensus recommendations for empirical treatment of uncomplicated cystitis with anti-infectives in noncatheterized older nursing home residents to be implemented in the Improving Outcomes of UTI Management in Long-Term Care Project (IOU) funded by the Agency for Healthcare Research and Quality. DESIGN: Two-round modified Delphi survey. PARTICIPANTS: Expert panel of 19 clinical pharmacists. MEASUREMENTS: Comprehensive literature search and development/review/edit of draft survey by the investigative group (one geriatric clinical pharmacist, two geriatric medicine physicians, and one infectious disease physician). The expert panel members rated their agreement with each of 31 recommendations for drugs of choice, dosing medications at various levels of renal function, drug-drug interactions to avoid, and duration of therapy by sex on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Consensus agreement was defined as a lower 95% confidence limit of 4.0 or higher for the recommendation-specific mean score. RESULTS: The response rate was 95% for the first round, and three recommendations achieved consensus (dosing for nitrofurantoin and trimethoprim/sulfamethoxazole in those without chronic kidney disease, and drug-drug interaction between trimethoprim/sulfamethoxazole and warfarin). In the second round, 90% responded and reached consensus on an additional eight recommendations (two for nitrofurantoin or trimethoprim/sulfamethoxazole as initial drugs of choice, three for dosing ciprofloxacin, nitrofurantoin, and trimethoprim/sulfamethoxazole at various levels of chronic kidney disease, and three drug-drug interactions to avoid: trimethoprim/sulfamethoxazole with phenytoin and ciprofloxacin with theophylline or with tizanidine). CONCLUSION: An expert panel of clinical pharmacists was able to reach consensus on a set of recommendations for the empirical treatment of cystitis with oral anti-infective medications in older nursing home residents. The recommendations were incorporated into a treatment algorithm for uncomplicated cystitis in noncatheterized nursing home residents and used in educational materials for health professionals in an ongoing controlled intervention study. J Am Geriatr Soc 67:539-545, 2019.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Hanlon JT, Perera S, Drinka PJ, et al. The IOU Consensus Recommendations for Empirical Therapy of Cystitis in Nursing Home Residents. J Am Geriatr Soc. 2018. PMID: 30584657. doi:10.1111/jgs.15726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。